We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.29B
AUM Growth
-$15.1M
Cap. Flow
+$17.3M
Cap. Flow %
1.33%
Top 10 Hldgs %
69%
Holding
47
New
3
Increased
3
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
SGMT icon
Sagimet Biosciences
SGMT
+$51.3M
2
GOSS icon
Gossamer Bio
GOSS
+$14.1M
3
GERN icon
Geron
GERN
+$3.88M
4
SVRA icon
Savara
SVRA
+$1.19M
5
IMA
ImageneBio Inc
IMA
+$911K

Top Sells

Rank Stock Value
1
BGRY
Berkshire Grey, Inc. Class A Common Stock
BGRY
+$53.8M
2
ACRV icon
Acrivon Therapeutics
ACRV
+$594K
3
EAR
Eargo, Inc. Common Stock
EAR
+$404K

Sector Composition

Rank Sector Weight
1 Healthcare 74.22%
2 Consumer Staples 18.57%
3 Technology 3.84%
4 Industrials 2.91%
5 Communication Services 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSBR icon
26
Champions Oncology
CSBR
$72.1M
$10.6M 0.82%
1,713,720
– –
INZY
27
DELISTED
Inozyme Pharma
INZY
$10.2M 0.79%
2,437,689
– –
TUYA
28
Tuya Inc
TUYA
$1.1B
$7.65M 0.59%
4,934,640
– –
CBIO
29
Crescent Biopharma
CBIO
$626M
$7.15M 0.55%
47,644
– –
IVA
30
Inventiva
IVA
$1.13B
$6.35M 0.49%
1,462,586
– –
BZFD icon
31
BuzzFeed
BZFD
$96.6M
$5.86M 0.45%
3,833,473
– –
UTRS
32
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$5.66M 0.44%
1,721,853
– –
NKTX icon
33
Nkarta
NKTX
$172M
$4.96M 0.38%
3,568,781
– –
MRKR icon
34
Marker Therapeutics
MRKR
$18.7M
$4.86M 0.38%
1,071,428
– –
ACRV icon
35
Acrivon Therapeutics
ACRV
$74M
$4.11M 0.32%
430,252
-51,425
-11% -$594K
RGLS
36
DELISTED
Regulus Therapeutics
RGLS
$2.67M 0.21%
1,945,579
– –
LXRX icon
37
Lexicon Pharmaceuticals
LXRX
$1.1B
$2.6M 0.2%
2,382,286
– –
AFMD
38
DELISTED
Affimed
AFMD
$2.12M 0.16%
442,649
– –
SNTI icon
39
Senti Biosciences Holdings
SNTI
$11M
$1.83M 0.14%
442,615
– –
IMA
40
ImageneBio Inc
IMA
$64.6M
$707K 0.05%
+15,123
New +$911K
SYBX
41
DELISTED
Synlogic
SYBX
$615K 0.05%
281,929
– –
SRFM icon
42
Surf Air Mobility
SRFM
$95.8M
$610K 0.05%
+62,917
New +$748K
ADXN
43
Addex Therapeutics
ADXN
$7.34M
$408K 0.03%
9,000
– –
UP icon
44
Wheels Up
UP
$198M
$220K 0.02%
5,306
– –
EAR
45
DELISTED
Eargo, Inc. Common Stock
EAR
$189K 0.01%
86,946
-120,940
-58% -$404K
AKTX
46
Akari Therapeutics
AKTX
$12.3M
$89.3K 0.01%
565
– –
BGRY
47
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
– –
-38,183,023
Closed -$53.8M
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
SFI
Siemens Fonds Invest Munich, Germany $1.75B AUM 26.24% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

NEA Management Company's Q3 2023 Portfolio in Review

As of Q3 2023, NEA Management Company held 47 positions worth $1.29B, down 1.2% from $1.31B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

NEA Management Company's Q3 2023 filing shows 3 new, 3 increased, 2 reduced and 1 closed positions. Its largest new stake was Sagimet Biosciences: 3,850,275 shares worth $27.1M. The largest sale was Berkshire Grey, Inc. Class A Common Stock, an estimated $53.8M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 77% a quarter earlier, followed by Consumer Staples and Technology.

  • NEA Management Company's largest Q3 2023 buy was Sagimet Biosciences: 3,850,275 shares worth $27.1M.
  • NEA Management Company added most to Gossamer Bio in Q3 2023, an estimated $14.1M increase.
  • NEA Management Company's biggest Q3 2023 reduction was Acrivon Therapeutics, cutting an estimated $594K.
  • NEA Management Company fully exited Berkshire Grey, Inc. Class A Common Stock in Q3 2023, selling an estimated $53.8M.
  • NEA Management Company's ten largest holdings make up 69% of its $1.29B portfolio in Q3 2023.
  • NEA Management Company opened 3 new positions and closed 1 in Q3 2023.
  • NEA Management Company's portfolio value fell 1.2% quarter-over-quarter to $1.29B.

Based on NEA Management Company's 13F filing for Q3 2023, filed 14 Nov 2023.